SRPT 最新季度財報
公佈日期11/5/2026
實際每股收益(美元)-0.27
實際營收(美元)381.35M
本頁面提供詳細的 Sarepta Therapeutics Inc 財報數據,包括最新財報、下一次財報發佈日期、歷史數據,以及 Sarepta Therapeutics Inc 財報法說會相關新聞。
| 發布日期 | 報告期末 | 每股收益/預測值 | 營收/預測值 | 每股收益超出預期幅度% | 營收超出預期幅度% |
|---|---|---|---|---|---|
| 11/5/2026 | 09/2026 | -0.27/0.06 | 381.35M/352.96M | -520.47% | 8.04% |
| 8/5/2026 | 06/2026 | -0.05/0.26 | 401.25M/364.34M | -118.02% | 10.13% |
| 5/6/2026 | 03/2026 | 3.15/0.99 | 730.80M/455.86M | 217.81% | 60.31% |
| 2/25/2026 | 12/2025 | -2.70/-1.23 | 442.93M/391.92M | -119.19% | 13.02% |
| 11/3/2025 | 09/2025 | -1.80/-0.82 | 399.36M/338.71M | -120.17% | 17.91% |
| 8/6/2025 | 06/2025 | 2.01/0.75 | 611.09M/529.98M | 167.63% | 15.30% |
| 5/6/2025 | 03/2025 | -4.60/-0.95 | 744.86M/683.36M | -385.40% | 9.00% |
| 2/26/2025 | 12/2024 | 1.65/1.90 | 658.41M/627.58M | -12.93% | 4.91% |
Sarepta Therapeutics (SRPT) 2026 年第三季法說會:隨 Elevidys 趨穩上調財測指引